Propranolol (a non-selective antagonist of ADRB1 and ADRB2) is clinically approved for the treatments of hypertension, cardiovascular diseases, anxiety and tremor [209,210] and could be repurposed for PCa treatment [21]. This evidence concerns the gene ADRB2 and posterior cortical atrophy.